Those taking GLP-1s had small but significant reductions in their 10-year chances of vertebral fractures, suggesting that the ...

RELATED: The No. 1 Ozempic Side Effect “Nobody Warns About.” ...

Medicines and Healthcare products Regulatory Agency experts have issued a stern warning over two particular brands ...

Danish obesity drug maker Novo Nordisk's new CEO risks being on the losing side of a damaging price war as "unprecedented" ...

There’s no denying the popularity of weight-loss drugs in the United States, with one in eight adults relying on GLP-1s to ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro to lose weight.

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

By Michael Erman and Mrinalika Roy Feb 3 (Reuters) - Pfizer on Tuesday released trial data on a high-profile obesity drug ...

In December 2025, the U.S. Food and Drug Administration gave the green light to a pill version of the blockbuster weight loss drug Wegovy, the first FDA-approved daily oral GLP-1 medication for ...

The world is in the middle of a peptide drug revolution. These short chains of amino acids—the building blocks of ...

'It only makes sense that the weight of passengers impacts costs,' an equity analyst for a financial firm said ...